AB0462 Up to 5-year retention of abatacept in belgian patients with moderate-to-severe ra: prospective data from the real-world action study
Verfasser: | |
---|---|
Dokumenttyp: | proceedings-article |
Erscheinungsdatum: | 2018 |
Verlag/Hrsg.: |
BMJ Publishing Group Ltd and European League Against Rheumatism
|
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-28502227 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1136/annrheumdis-2018-eular.1647 |